<DOC>
	<DOCNO>NCT02968082</DOCNO>
	<brief_summary>A Single-center , randomize , prospective , experimental , double-blind comparison study effect preoperative scopolamine patch application postoperative nausea vomit microvascular decompression surgery</brief_summary>
	<brief_title>The Effects Preoperative Scopolamine Patch Application Postoperative Nausea Vomiting MVD Surgery</brief_title>
	<detailed_description>1 . Study design plan 1-1 ) Sixty envelop prepared : Thirty envelope scopolamine patch experimental group 30 placebo patch control group . Each envelope tag QR code , randomly mixed number 1 60 . QR code identify discontinuation study , researcher subject would know group envelope belong . 1-2 ) Patch apply ear opposite side operation , 9 p.m. day operation day . 1-3 ) Nausea assess Visual Analogue Scale ( VAS ) immediate arrival recovery room ward . After , nausea continuously assess every 4 hour ( 4hr , 8hr , 12hr , 16hr , 20hr , 24hr surgery ) number vomit also count . Basic clinical characteristic number antiemetic administration identify medical record . 2 . Efficacy assessment 2-1 ) Degree nausea : Visual Analogue Scale ( VAS ) Subjects describe subject degree nausea VAS score , immediate arrival recovery room ward 4hr , 8hr , 12hr , 16hr , 20hr , 24hr surgery . Respondents specify degree nausea indicate point along continuous 10cm line two end-points ; leave one `` No nausea '' right one `` Very severe nausea '' . Scoring base length leave point high score mean severe degree nausea . 2-2 ) Number vomit Number vomit count immediate arrival recovery room ward , 4hr , 8hr , 12hr , 16hr , 20hr , 24hr operation record . If vomiting , record `` 0 '' . 2-3 ) Number antiemetic administration It record immediate arrival recovery room ward , 4hr , 8hr , 12hr , 16hr , 20hr , 24hr operation . The kind antiemetic use dosage number administration identify medical record . 2-4 ) Type antiemetic time administration 2-4-1 ) PRN ) Meckool 10mg/2ml 1amp IVs When VAS 5 subject want minimum interval 6hour maximum three time . If improvement , notice . 2-4-2 ) PRC ) Nasea 0.3mg 1amp IVs 3 . Statistical plan 3-1 ) General characteristic clinical characteristic analyzed frequency , percentage , mean value standard deviation . 3-2 ) Homogeneity variances experimental group control group analyze Chi-square test , t-test Fisher 's exact test 3-3 ) Degree nausea experimental group control group recovery room ward , 4hr , 8hr , 12hr , 16hr , 20hr , 24hr operation analyze Student 's t-test . 3-4 ) Number vomit antiemetic administration experimental group control group analyze Fisher 's exact test . 3-5 ) Hospitalization period experimental group control group analyze Student 's t-test . 4 . Experimental group scopolamine patch application expect less severity nausea few number vomit antiemetic usage . Ultimately , may relate hospitalization period decrease .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>1 . Those either hemifacial spasm trigeminal neuralgia , undergo microvascular decompression ( MVD ) , understand study objective voluntarily consent participation . 2 . Adequate communication ability enough understand answer questionnaire . 3 . Age ≥ 18 year , ≤ 65 year . 4 . ASA Physical Status Classification 1 2 . Class 1 : A normal healthy patient Class 2 : A patient mild systemic disease 5 . Those discharged general ward , intensive care unit ( ICU ) operation 6 . Normal liver kidney function 1 . More one craniotomy period admission 2 . Pregnant lactate woman 3 . Narrowangle glaucoma 4 . Pyloric stenosis , intestinal obstruction , bladder obstruction 5 . Bradycardia 6 . Voiding difficulty benign prostate hypertrophy ( BPH ) 7 . Any history hypersensitivity ointment base scopolamine patch</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>MVD</keyword>
	<keyword>Scopolamine</keyword>
	<keyword>Microvascular Decompression</keyword>
</DOC>